Technology | Molecular Health

Dataome

The world’s medical data, cleaned and curated

At the center of action is insight. At the center of insight is Dataome. Built and constructed over a decade, our Dataome technology enables the quality-controlled capture, integration and analysis of clinical and molecular knowledge. By connecting real-world patient outcome data to the up-to-date state of clinical and molecular knowledge, Dataome provides an unparalleled evidence base upon which decision support solutions for the healthcare industry are built.

MH Predict Logo MH Guide Logo MH Mendel Logo MH BRCA Logo
MH Predict Logo MH Guide Logo MH Mendel Logo MH BRCA Logo

Capture and quality assurance
of global data and knowledge about interventions, outcomes and molecular mechanisms.

Integrates and contextualizes
the world‘s clinico-molecular evidence data into knowledge. It powers our precision medicine analytics.

Precision analytics
empowering evidence-driven decision support for treatment decisions and drug development.

Technology to make a data-driven difference

Dataome empowers the capture and transformation of clinical and molecular data into real-life applications for clinical discovery and superior decision-making.  

 

Designed and developed for over a decade, the technology is composed of three essential innovations:

 

  • Dataome Capture – the technologies that capture, curate and integrate global biomedical data
  • Dataome Knowledgebase – the global evidence-base of clinico-molecular data and knowledge
  • Dataome Analytics – the delivery of evidence-based decision support and discovery for the healthcare industry

Our Dataome technology platform mines and structures millions of evidence-based molecular and clinical data sources. Healthcare professionals can deep dive into a knowledge base that contains curated biomarkers of drug response, resistance, and toxicity, drawn from the world’s biomedical literature.

Our Dataome technology platform provides fast clinico-molecular data interpretation that has relevance across the healthcare industry – from anticipating patient-cohort drug response, to identifying personalized treatment options for patients, to predicting drug toxicity and side effects based on genomic and molecular evidence.

Our Dataome technology platform intelligently structures and delivers data to enable automated, real-time access. From interactive interpretation of patient genome data for labs to customized network integration with hospital groups, we are continuously forging new channels to deliver relevant data to suit our customer requirements.

Integrating insight has never been easier

Over the last decade, Dataome has grown to become one of the largest globally available resources of clinico-molecular data and knowledge. From millions of patient lives to hundreds of billions of molecular data points, it provides a single-point of access to the worlds biomedical knowledge through our decision support applications.


Molecular Health Guide (MH Guide) identifies safe and effective therapies for patients by analyzing the molecular profile. It matches detected mutations to the world’s knowledge in the field of oncology and hereditary diseases and helps medical experts to create a patient-specific clinical report. MH Guide is an IVD registered in the EU.

 

Molecular Health Guide Mendel (MH Mendel) supports human geneticists to identify clinically significant genetic variants and create a diagnostic report for individual patients. MH Mendel is part of the Molecular Health Guide (MH Guide) which solution which is an IVD registered in the EU. 


Logo of MH BRCA


Molecular Health Guide BRCA (MH BRCA) supports medical professionals in identifying and reporting clinically significant germline variants associated with hereditary breast and ovarian cancer (HBOC) syndrome from NGS-based assessment of BRCA1 and BRCA2 and other HBOC related genes. MH BRCA is part of the Molecular Health Guide (MH Guide) solution which is an IVD registered in the EU.

MH Predict Logo


Molecular Health Predict (MH Predict) is an application to predict clinical trials probabilities of success. It enables the improvement of clinical trial success and reduces clinical trial failure while optimizing resource allocation for the biopharma industry and investors and enhancing the overall efficiency of drug development.

 

Let’s talk about how our technology can work for you

To find out more, you can call our customer care team or help desk or send us an e-mail. We would be delighted to provide you with more information or answer your questions.


EU: +49 6221 43851-150
E-Mail: CustomerCareEU@molecularhealth.com